Table 3.
Ventriculographic and Echocardiographic Measures Obtained Just Prior to CSD Implantation (Pre-treatment) and at the End of Follow-Up (Post-treatment) in CSD-Treated Dogs.
Moderate HF (n=6) | Advanced HF (n=6) | |||
---|---|---|---|---|
Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | |
LV EF (%) | 34±1 | 42±1* | 25±1 | 27±1 |
LAVmax (ml) | 22.37±1.44 | 19.50±0.74* | 28.42±1.58 | 28.05±1.63 |
LAVp (ml) | 16.47±0.99 | 13.75±1.02* | 21.10±1.4 | 20.35±0.79 |
LAVmin (ml) | 14.35±1.02 | 11.65±0.94* | 19.00±1.20 | 17.67±0.82 |
LAAEV (ml) | 2.12±0.19 | 2.10±0.11 | 2.12±0.2 | 2.70±0.24 |
LAAEF (%) | 13.17±1.38 | 15.02±0.8 | 9.98±0.77 | 13.12±1.28 |
Abbreviations as in Table 1.
p<0.05 vs. Pre-treatment.